AMC MCQ → Gastroenterology and hepatology
Gastroenterology and hepatology accounts for roughly 4% of the AMC MCQ blueprint. This bank has 172 items tagged to it.
Around 4% of the paper, per AMC examination specifications and clinical handbook. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
A 32 year old woman has 18 months of intermittent diarrhoea, bloating, tiredness and 6 kg of weight loss, and is found to have iron deficiency anaemia despite normal periods. She is still eating a normal diet. Her tissue transglutaminase IgA is strongly positive with a normal total IgA, and duodenal biopsy shows villous atrophy. What is the most likely diagnosis?
The point: Coeliac disease is an immune reaction to gluten that damages the small bowel mucosa, and it is far commoner and more varied than the classic picture suggests. It can present with diarrhoea, bloating, weight loss and steatorrhoea, but also with iron, folate or vitamin deficiency, unexplained anaemia, fatigue, mouth ulcers, an itchy blistering rash called dermatitis herpetiformis, osteoporosis, or simply abnormal liver enzymes, and in children with faltering growth. Testing must be done while the patient is still eating gluten, because a gluten-free diet normalises the results. The first-line test is serology, tissue transglutaminase IgA with a total IgA to detect deficiency, and a positive result is confirmed by duodenal biopsy showing villous atrophy. Associated conditions include type 1 diabetes and autoimmune thyroid disease, and there is an increased risk of small bowel lymphoma in untreated disease. Treatment is a lifelong strict gluten-free diet, which resolves symptoms and reduces the long-term risks, with correction of deficiencies, a bone density assessment and dietitian support. Serology is used to monitor adherence. First-degree relatives should be offered testing.
Source: Therapeutic Guidelines (Australia) — Gastrointestinal: coeliac disease Therapeutic Guidelines (Australia) · tier 3, national formulary
A 32 year old woman has 18 months of intermittent diarrhoea, bloating, tiredness and 6 kg of weight loss, and is found to have iron deficiency anaemia despite normal periods. She is still eating a normal diet. Her tissue transglutaminase IgA is strongly positive with a normal total IgA, and duodenal biopsy shows villous atrophy. What is the most appropriate initial investigation?
The point: Coeliac disease is an immune reaction to gluten that damages the small bowel mucosa, and it is far commoner and more varied than the classic picture suggests. It can present with diarrhoea, bloating, weight loss and steatorrhoea, but also with iron, folate or vitamin deficiency, unexplained anaemia, fatigue, mouth ulcers, an itchy blistering rash called dermatitis herpetiformis, osteoporosis, or simply abnormal liver enzymes, and in children with faltering growth. Testing must be done while the patient is still eating gluten, because a gluten-free diet normalises the results. The first-line test is serology, tissue transglutaminase IgA with a total IgA to detect deficiency, and a positive result is confirmed by duodenal biopsy showing villous atrophy. Associated conditions include type 1 diabetes and autoimmune thyroid disease, and there is an increased risk of small bowel lymphoma in untreated disease. Treatment is a lifelong strict gluten-free diet, which resolves symptoms and reduces the long-term risks, with correction of deficiencies, a bone density assessment and dietitian support. Serology is used to monitor adherence. First-degree relatives should be offered testing.
Source: Therapeutic Guidelines (Australia) — Gastrointestinal: coeliac disease Therapeutic Guidelines (Australia) · tier 3, national formulary
A 32 year old woman has 18 months of intermittent diarrhoea, bloating, tiredness and 6 kg of weight loss, and is found to have iron deficiency anaemia despite normal periods. She is still eating a normal diet. Her tissue transglutaminase IgA is strongly positive with a normal total IgA, and duodenal biopsy shows villous atrophy. What is the most appropriate next step in management?
The point: Coeliac disease is an immune reaction to gluten that damages the small bowel mucosa, and it is far commoner and more varied than the classic picture suggests. It can present with diarrhoea, bloating, weight loss and steatorrhoea, but also with iron, folate or vitamin deficiency, unexplained anaemia, fatigue, mouth ulcers, an itchy blistering rash called dermatitis herpetiformis, osteoporosis, or simply abnormal liver enzymes, and in children with faltering growth. Testing must be done while the patient is still eating gluten, because a gluten-free diet normalises the results. The first-line test is serology, tissue transglutaminase IgA with a total IgA to detect deficiency, and a positive result is confirmed by duodenal biopsy showing villous atrophy. Associated conditions include type 1 diabetes and autoimmune thyroid disease, and there is an increased risk of small bowel lymphoma in untreated disease. Treatment is a lifelong strict gluten-free diet, which resolves symptoms and reduces the long-term risks, with correction of deficiencies, a bone density assessment and dietitian support. Serology is used to monitor adherence. First-degree relatives should be offered testing.
Source: Therapeutic Guidelines (Australia) — Gastrointestinal: coeliac disease Therapeutic Guidelines (Australia) · tier 3, national formulary
Cardiology and vascular · Respiratory · Renal and urology · Endocrinology and metabolic · Neurology · Haematology · Rheumatology and musculoskeletal · Infectious diseases · Dermatology · Ophthalmology · Ear, nose and throat · Surgery · Emergency, trauma and toxicology · Women's health · Child health · Mental health · Population health and ethics